4.3 Article

Total healthcare cost savings through improved bipolar I disorder identification using the Rapid Mood Screener in patients diagnosed with major depressive disorder

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

The real-world health resource use and costs of misdiagnosing bipolar I disorder

Roger S. McIntyre et al.

Summary: This study compared healthcare resource utilization and costs between bipolar I disorder (BP-I) patients initially misdiagnosed with major depressive disorder (MDD) and BP-I patients without a prior MDD diagnosis. The results showed that misdiagnosed BP-I patients had significantly higher rates of hospitalizations, emergency room visits, outpatient visits, and total healthcare costs compared to BP-I only patients.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Article Medicine, General & Internal

The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder

Roger S. McIntyre et al.

Summary: The study developed a pragmatic 6-item Rapid Mood Screener (RMS) that successfully differentiates bipolar I disorder from MDD in patients with depressive symptoms. The RMS showed improved accuracy and predictive value compared to the Mood Disorder Questionnaire in the same analysis sample, while using 60% fewer items.

CURRENT MEDICAL RESEARCH AND OPINION (2021)

Article Medicine, General & Internal

Bipolar disorders

Roger S McIntyre et al.

LANCET (2020)

Review Health Care Sciences & Services

The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review

Leona Bessonova et al.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2020)

Review Clinical Neurology

Differentiating between bipolar and unipolar depression in functional and structural MRI studies

Kyu-Man Han et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)

Article Clinical Neurology

The economic burden of bipolar I disorder in the United States in 2015

Martin Cloutier et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Review Pharmacology & Pharmacy

Epidemiology and risk factors for bipolar disorder

Tobias A. Rowland et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)

Article Psychiatry

First-episode types in bipolar disorder: predictive associations with later illness

R. J. Baldessarini et al.

ACTA PSYCHIATRICA SCANDINAVICA (2014)

Review Clinical Neurology

The prevalence and burden of bipolar depression

Shefali Miller et al.

JOURNAL OF AFFECTIVE DISORDERS (2014)

Review Neurosciences

Neurocognitive Impairment Across the Bipolar Spectrum

B. Sole et al.

CNS NEUROSCIENCE & THERAPEUTICS (2012)

Article Psychology, Clinical

A Model of the Economic Impact of a Bipolar Disorder Screening Program in Primary Care

Joseph Menzin et al.

JOURNAL OF CLINICAL PSYCHIATRY (2009)

Review Clinical Neurology

Diagnostic guidelines for bipolar depression: a probabilistic approach

Philip B. Mitchell et al.

BIPOLAR DISORDERS (2008)

Article Psychiatry

Validity of the Mood Disorder Questionnaire: A general population study

RMA Hirschfeld et al.

AMERICAN JOURNAL OF PSYCHIATRY (2003)